Verified ComparisonLast updated: 27 March 2026
MOTS-c vs Thymosin Alpha-1
MOTS-c is a mitochondrial signalling peptide; thymosin-alpha-1 modulates immune and thymic function. Both are studied in aging and longevity contexts.
MOTS-c
Longevity
3.8/ 5
B+
Thymosin Alpha-1
Immune
3.9/ 5
B+
Editor's note
MOTS-c targets mitochondrial health; thymosin-alpha-1 targets immune function.
| Criterion | MOTS-c | Thymosin Alpha-1 |
|---|---|---|
| Mechanism | Mitochondrial signalling | Immune modulation |
| Research focus | Metabolic health, mitochondria | Immune system, thymic |
| Evidence breadth | Growing mechanistic | More established |
| Aging-axis coverage | Mitochondrial | Immune-aging |
| Human trial data | Very limited | Some clinical data |
Frequently asked questions
Thymosin-alpha-1 has more clinical data; MOTS-c has growing mechanistic evidence.
Want to read the full reviews?